bcwy personal page - To The Moon

bcwy

No personal profile

0Follow

1Followers

0Topic

0Badge

2021-06-18

Ford looks good to buy

Sorry, the original content has been removed

2021-06-18

Apple will dip all the way

Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say

2021-06-18

Meme stocks

With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today

2021-06-18

This is so sad

Orphazyme shares tumbled more than 60% in pre-market trading

2021-06-18

Shell out more money

Sorry, the original content has been removed

2021-06-17

How do we ultimately say who "deserves" it.

Sorry, the original content has been removed

2021-06-18

Wow so many comments here

Sorry, the original content has been removed

2021-06-18

Uh oh, maybe business will fold soon

Sorry, the original content has been removed

2021-06-18

Wow who would've guessed

Sorry, the original content has been removed

2021-06-18

Great job

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582871469502818","uuid":"3582871469502818","gmtCreate":1619778373061,"gmtModify":1619778373061,"name":"bcwy","pinyin":"bcwy","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":0,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":166644647,"gmtCreate":1624008474089,"gmtModify":1703826433205,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Shell out more money","listText":"Shell out more money","text":"Shell out more money","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166644647","repostId":"1181667218","repostType":4,"isVote":1,"tweetType":1,"viewCount":2507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166642240,"gmtCreate":1624008407380,"gmtModify":1703826430938,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Uh oh, maybe business will fold soon","listText":"Uh oh, maybe business will fold soon","text":"Uh oh, maybe business will fold soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166642240","repostId":"1176081814","repostType":4,"isVote":1,"tweetType":1,"viewCount":3006,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166646213,"gmtCreate":1624008372332,"gmtModify":1703826429326,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Uh oh orphazyme","listText":"Uh oh orphazyme","text":"Uh oh orphazyme","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166646213","isVote":1,"tweetType":1,"viewCount":2727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166648869,"gmtCreate":1624008279651,"gmtModify":1703826427502,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Ok here we go","listText":"Ok here we go","text":"Ok here we go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166648869","repostId":"2143926717","repostType":2,"repost":{"id":"2143926717","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623854867,"share":"https://ttm.financial/m/news/2143926717?lang=en_US&edition=fundamental","pubTime":"2021-06-16 22:47","market":"us","language":"en","title":"At Home Group accepts Hellman & Friedman's raised offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2143926717","media":"Reuters","summary":"June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equ","content":"<p>June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman &amp; Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.</p>\n<p>Plano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.</p>\n<p>Honest Capital said in May, in a letter to At Home, the initial offer from Hellman &amp; Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.</p>\n<p>At Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.</p>\n<p>\"This price increase represents our best and final offer,\" Hellman &amp; Friedman Partner Erik Ragatz said in a statement on Wednesday.</p>\n<p>H&amp;F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.</p>\n<p>Honest Capital could not be immediately reached for a comment, and CAS did not immediately respond.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>At Home Group accepts Hellman & Friedman's raised offer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAt Home Group accepts Hellman & Friedman's raised offer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-16 22:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman &amp; Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.</p>\n<p>Plano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.</p>\n<p>Honest Capital said in May, in a letter to At Home, the initial offer from Hellman &amp; Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.</p>\n<p>At Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.</p>\n<p>\"This price increase represents our best and final offer,\" Hellman &amp; Friedman Partner Erik Ragatz said in a statement on Wednesday.</p>\n<p>H&amp;F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.</p>\n<p>Honest Capital could not be immediately reached for a comment, and CAS did not immediately respond.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HOME":"At Home Group Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143926717","content_text":"June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman & Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.\nPlano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.\nHonest Capital said in May, in a letter to At Home, the initial offer from Hellman & Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.\nAt Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.\n\"This price increase represents our best and final offer,\" Hellman & Friedman Partner Erik Ragatz said in a statement on Wednesday.\nH&F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.\nHonest Capital could not be immediately reached for a comment, and CAS did not immediately respond.","news_type":1,"symbols_score_info":{"HOME":0.9}},"isVote":1,"tweetType":1,"viewCount":2387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166648341,"gmtCreate":1624008259483,"gmtModify":1703826427179,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Wow who would've guessed","listText":"Wow who would've guessed","text":"Wow who would've guessed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166648341","repostId":"1113093847","repostType":4,"isVote":1,"tweetType":1,"viewCount":2686,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641587,"gmtCreate":1624008226649,"gmtModify":1703826426373,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"This is so sad","listText":"This is so sad","text":"This is so sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641587","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=en_US&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1,"symbols_score_info":{"ORPH":0.9}},"isVote":1,"tweetType":1,"viewCount":3548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641861,"gmtCreate":1624008197353,"gmtModify":1703826426041,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Ford looks good to buy&nbsp;","listText":"Ford looks good to buy&nbsp;","text":"Ford looks good to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641861","repostId":"2144172072","repostType":4,"isVote":1,"tweetType":1,"viewCount":4643,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641940,"gmtCreate":1624008161080,"gmtModify":1703826425716,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"They will always win","listText":"They will always win","text":"They will always win","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166641940","repostId":"2144861727","repostType":2,"isVote":1,"tweetType":1,"viewCount":3065,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168358986,"gmtCreate":1623953223445,"gmtModify":1703824605541,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Post here","listText":"Post here","text":"Post here","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168358986","isVote":1,"tweetType":1,"viewCount":2796,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351480,"gmtCreate":1623953188340,"gmtModify":1703824605213,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Apple try harder","listText":"Apple try harder","text":"Apple try harder","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168351480","repostId":"1139981231","repostType":2,"repost":{"id":"1139981231","kind":"news","pubTimestamp":1623910261,"share":"https://ttm.financial/m/news/1139981231?lang=en_US&edition=fundamental","pubTime":"2021-06-17 14:11","market":"us","language":"en","title":"Apple Struggles in Push to Make Healthcare Its Greatest Legacy","url":"https://stock-news.laohu8.com/highlight/detail?id=1139981231","media":"The Wall Street Journal","summary":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leade","content":"<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cdcc89ff3fd1e1d8ec3f02f3aaf52457\" tg-width=\"1260\" tg-height=\"840\" referrerpolicy=\"no-referrer\"><span>Under the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.</span></p>\n<p>Apple&nbsp;Inc.&nbsp;Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.</p>\n<p>Apple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.</p>\n<p>Today those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.</p>\n<p>The new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.</p>\n<p>An Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as&nbsp;heart-rate notifications&nbsp;in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.</p>\n<p>“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.</p>\n<p>Looking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com&nbsp;Inc.’s&nbsp;high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch&nbsp;virtual care across 50 states.</p>\n<p>Under Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.</p>\n<p>Apple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.</p>\n<p>One of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.</p>\n<p>Apple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/837161c8fc0a7b93c5c67936fe293453\" tg-width=\"1260\" tg-height=\"840\"><span>Apple Chief Operating Officer Jeff Williams oversees its health unit.</span></p>\n<p>The team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.</p>\n<p>If Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.</p>\n<p>To start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.</p>\n<p>The effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.</p>\n<p>Dr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.</p>\n<p>Those issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.</p>\n<p>Apple’s spokesman said such criticisms are inaccurate.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/01a35a283d15f6de16455cae846a617b\" tg-width=\"1260\" tg-height=\"840\"><span>Dr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.</span></p>\n<p>Employees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.</p>\n<p>Apple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.</p>\n<p>The spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.</p>\n<p>Mr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.</p>\n<p>In addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.</p>\n<p>A recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.</p>\n<p>HealthHabit&nbsp;offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.</p>\n<p>Half the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.</p>\n<p>Data supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.</p>\n<p>During a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.</p>\n<p>In the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.</p>\n<p>Rival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.</p>\n<p>The Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Struggles in Push to Make Healthcare Its Greatest Legacy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Struggles in Push to Make Healthcare Its Greatest Legacy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 14:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 ...</p>\n\n<a href=\"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.wsj.com/articles/apple-struggles-in-push-to-make-healthcare-greatest-legacy-11623832200?mod=hp_lead_pos3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139981231","content_text":"Tech giant has envisioned hiring doctors to offer primary care, now focused on Watch\nUnder the leadership of CEO Tim Cook, Apple has increased its research-and-development budget eightfold to $20 billion annually.\nApple Inc. Chief Executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the healthcare sector have struggled to gain traction, according to people familiar with them and documents reviewed by The Wall Street Journal.\nApple has envisioned an audacious plan for healthcare, offering its own primary-care medical service with Apple-employed doctors at its own clinics, according to people familiar with the plan and documents. To test that and other bold healthcare ideas, it took over clinics that catered to its employees and built a team with scores of clinicians, engineers, product designers and others.\nToday those ambitions, which aren’t widely known, have largely stalled as Apple has shifted the focus of its health unit to something it knows well: Selling devices, specifically the Apple Watch, according to people familiar with its strategy.\nThe new primary-care service hasn’t gotten off the ground, people familiar with it say. A digital health app launched quietly this year has struggled to keep users engaged, say people familiar with the app and the documents seen by the Journal. Some employees have raised questions internally about the integrity of health data coming from the company’s clinics that has been used to support product development, according to people familiar with their concerns and the documents.\nAn Apple spokesman said data integrity is the foundation for all of the company’s innovations. He pointed to the accomplishments of its health team and said the company is still in the early innings of its work in healthcare, adding that new technology such as heart-rate notifications in products like the Apple Watch have improved users’ health. He said data gathered by Apple’s devices is enabling new research that has the potential to improve care.\n“Many of the assertions in this report are based on incomplete, outdated and inaccurate information,” the spokesman said.\nLooking for new markets where technology can improve efficiency and outcomes—and power sales growth—the tech sector has eyed healthcare as an untapped opportunity. Some of tech’s biggest efforts have failed, includingHaven,Amazon.com Inc.’s high-profile partnership with other companies that aimed to reduce healthcare costs. Today, Amazon has a new effort to sell prescriptions and a plan to launch virtual care across 50 states.\nUnder Mr. Cook’s leadership, Apple has increased its research-and-development budget eightfold to $20 billion annually, according to its public filings. And besides a smartwatch, the company has released wireless headphones as well as new services. It has also invested heavily in health, autonomous driving and augmented reality, all technically complex, high-stakes areas, meaning that game-changing offerings could be years away or never come.\nApple can study markets for years before coming up with its own offering, and it sometimes works extensively on new projects or technologies that it ultimately doesn’t bring to market.\nOne of its most ambitious healthcare ideas was a plan to offer primary-care medicine, conceived in 2016, according to documents and the people familiar with the plan. An Apple team spent months trying to figure out how the flood of health and wellness data collected from users of its smartwatch, first released in 2015, might be used to improve healthcare, the people said.\nApple Chief Operating Officer Jeff Williams, who oversees the health team, urged employees to think big. He said Apple should disrupt what he called the “363” and “break fix” model of care in the U.S., where patients may not see their doctors 363 days a year and only visit when something goes wrong, according to people familiar with his ideas.\nApple Chief Operating Officer Jeff Williams oversees its health unit.\nThe team decided one of the best ways to realize that vision was to provide a medical service of its own, said people familiar with the plan, linking data generated by Apple devices with virtual and in-person care provided by Apple doctors. Apple would offer primary care, but also continuous health monitoring as part of a subscription-based personalized health program, according to these people and the documents.\nIf Apple could prove that its combination of device sensors, software and services could improve people’s health and lower costs, the company could franchise the model to health systems and even other countries, according to the documents.\nTo start, Apple chose to test the service out on its own employees. Apple took over employee health clinics near its headquarters that were being run by a startup and turned them into test beds for new health services, say people familiar with the changes. In 2017 it hired Dr. Sumbul Desai from Stanford University to run the effort, which was given the code name Casper, said the people familiar with the plan.\nThe effort continues today, but Apple has struggled to move Casper past a preliminary stage, say people familiar with its operations.\nDr. Desai’s unit in particular has seen multiple departures by employees who say its culture discourages critical feedback, which is potentially problematic for a unit focused on products and services related to personal health, according to people familiar with its culture and the documents. Some employees expressed concerns that internal data about the clinics’ performance, data that was recently used to support the rollout of a new digital health app, has been inaccurate or compiled haphazardly, according to the documents and people familiar with the data.\nThose issues have been repeatedly voiced to Messrs. Cook and Williams, according to the documents and people familiar with the issues.\nApple’s spokesman said such criticisms are inaccurate.\nDr. Sumbul Desai runs a team that oversees clinics, handles relations with regulators and spearheads research collaborations.\nEmployees concerned about the culture pointed to a 2019 meeting during which a midlevel manager raised questions about data, according to people familiar with the meeting and the documents. Dr. Desai responded angrily, leading some present to conclude that critical questions were unwelcome, according to the people and the documents. The manager left Apple weeks later and the episode contributed to her departure, documents show.\nApple’s spokesman said Dr. Desai spoke to the importance of data integrity in the meeting. “This matter was investigated thoroughly and the allegations could not be substantiated,” the spokesman said. Apple declined to comment on the circumstances of the employee’s departure.\nThe spokesman said the company is proud of Dr. Desai’s work and that she has been instrumental in much of its healthcare work.\nMr. Williams and Dr. Desai didn’t respond to a request for comment and Apple declined to make them available.\nIn addition to overseeing the clinics, known as AC Wellness, Dr. Desai’s team handles relations with regulators, spearheads research collaborations and provides clinical expertise on other health products at Apple.\nA recent initiative for Dr. Desai’s team, a digital health app called HealthHabit that is being tested on California-based Apple employees, has struggled with low engagement since the app’s launch roughly six months ago, according to documents and people familiar with the app.\nHealthHabit offers to connect people with clinicians via chat and encourages them to set health challenges such as “I will exercise more this week.” Those with a history of hypertension can be connected to health coaches who can send them a blood-pressure monitor and scale and advise them on healthier habits.\nHalf the people who had downloaded it as of May hadn’t enrolled and engagement among many who have enrolled has been low, according to the documents and people familiar with the app.\nData supporting the app’s hypertension program has caused new concerns among employees about the integrity of internal data and analysis, some of the people said.\nDuring a presentation for all Apple health employees in March, Mr. Williams praised the clinics’ results in treating hypertension and pointed to them as evidence supporting the HealthHabit app’s potential, according to people who saw the presentation. He suggested that the company may have wider ambitions for the app if it is successful, they said.\nIn the meeting, Mr. Williams showed data indicating that 91% of patients in Apple’s clinics with more severe stage-two hypertension improved to healthier stages or normal, according to documents reviewed by the Journal, a figure that some employees feared could overstate the clinics’ success, according to people who attended the meeting and documents.\nRival companies offering hypertension apps have disclosed lower rates of success. Hello Heart Inc. reported 23% of stage 2 patients saw a significant improvement in blood pressure at 6 weeks. Livongo claimed one-third of patients with stage one hypertension or worse improved to an elevated or normal range in 6 weeks. Mr. Williams’s data didn’t include a time frame, according to the documents.\nThe Apple spokesman said that other companies analyze their hypertension data differently and that the data cited by Mr. Williams in the meeting was for an internal pilot, not a product.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":2781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351110,"gmtCreate":1623953150130,"gmtModify":1703824604234,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"China big brother","listText":"China big brother","text":"China big brother","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168351110","repostId":"2144714222","repostType":2,"isVote":1,"tweetType":1,"viewCount":1051,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351085,"gmtCreate":1623953132847,"gmtModify":1703824603910,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Apple will dip all the way","listText":"Apple will dip all the way","text":"Apple will dip all the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/168351085","repostId":"2144745081","repostType":2,"repost":{"id":"2144745081","kind":"highlight","pubTimestamp":1623999815,"share":"https://ttm.financial/m/news/2144745081?lang=en_US&edition=fundamental","pubTime":"2021-06-18 15:03","market":"us","language":"en","title":"Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say","url":"https://stock-news.laohu8.com/highlight/detail?id=2144745081","media":"MarketWatch","summary":"Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indicatio","content":"<p>Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert to inflation risks.</p>\n<p>\"There is probably no bigger macro issue, both tactically and strategically, than inflation and what this means for portfolios,\" said strategists led by Inigo Fraser Jenkins at Bernstein Research on Thursday.</p>\n<p>Fraser Jenkins and his team have our call of the day: that investors should look to buy shares in companies with a long maturity of debt as an effective hedge against inflation.</p>\n<p>Companies issued debt at an astounding rate through the COVID-19 pandemic. Much of it was a necessary move to meet funding needs, but for some groups it was an opportunity to take advantage of the Fed's measures supporting credit markets, which provided an ability to increase the maturity of debt, the strategists said.</p>\n<p>According to the team at Bernstein, for companies that have long maturity of debt, have issued fixed-rate debt, and are going concerns -- i.e. can continue operating while meeting financial obligations -- inflation could be a positive thing. \"Inflation would erode the real value of the debt relative to earnings (which are tied to the real economy),\" the strategists said.</p>\n<p>\"There is no one solution\" to finding suitable hedges for inflation, Fraser Jenkins' group said, noting that a good response may involve more equities, real assets, gold, and even crypto assets like bitcoin . But \"another possible string to the inflation-hedging bow\" is companies that emerge from the pandemic with a long maturity of debt.</p>\n<p>\"A basket of U.S. long debt maturity stocks has outperformed a basket of short debt maturity stocks by 7% this year and trades at more attractive valuations than their short debt maturity peers,\" Fraser Jenkins and his team added.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1aca07448aa8168cf9edc9e49d933435\" tg-width=\"1260\" tg-height=\"672\" referrerpolicy=\"no-referrer\"><span>CHART VIA BERNSTEIN RESEARCH.</span></p>\n<p>There are a lot of these stocks: the strategists at Bernstein have a list of more than 80. Some of those picks include Big Tech names Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>(GOOGL), Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, and Microsoft <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, as well as other technology companies like videogame developer Electronic Arts <a href=\"https://laohu8.com/S/EA\">$(EA)$</a> and semiconductor groups Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, Texas Instruments <a href=\"https://laohu8.com/S/TXN\">$(TXN)$</a>, and Qualcomm <a href=\"https://laohu8.com/S/QCOM\">$(QCOM)$</a>.</p>\n<p>Telecom giants AT&amp;T <a href=\"https://laohu8.com/S/T\">$(T)$</a> and Verizon <a href=\"https://laohu8.com/S/VZ\">$(VZ)$</a> are also on the list, as are retailers and consumer-products groups such as Home Depot <a href=\"https://laohu8.com/S/HD\">$(HD)$</a>, Target <a href=\"https://laohu8.com/S/TGT\">$(TGT)$</a>, McDonalds <a href=\"https://laohu8.com/S/MCD\">$(MCD)$</a>, Starbucks <a href=\"https://laohu8.com/S/SBUX\">$(SBUX)$</a>, Nike <a href=\"https://laohu8.com/S/NKE\">$(NKE)$</a>, Kraft Heinz <a href=\"https://laohu8.com/S/KHC\">$(KHC)$</a>, Estée Lauder <a href=\"https://laohu8.com/S/EL\">$(EL)$</a>, and Coca-Cola <a href=\"https://laohu8.com/S/KO\">$(KO)$</a>.</p>\n<p>Health and biotechnology stocks like Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, Gilead Sciences <a href=\"https://laohu8.com/S/GILD\">$(GILD)$</a>, Regeneron <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a>, and Biogen <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> also make the cut, as do railroad operators Kansas City Southern <a href=\"https://laohu8.com/S/KSU\">$(KSU)$</a> and Union Pacific <a href=\"https://laohu8.com/S/UNP\">$(UNP)$</a>. Defense companies Lockheed Martin <a href=\"https://laohu8.com/S/LMT\">$(LMT)$</a>, Northrop Grumman <a href=\"https://laohu8.com/S/NOC\">$(NOC)$</a>, and Raytheon Technologies <a href=\"https://laohu8.com/S/RTX\">$(RTX)$</a> also qualify.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLooking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 15:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert...</p>\n\n<a href=\"https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMT":"洛克希德马丁","KO":"可口可乐","PFE":"辉瑞","AMZN":"亚马逊","KHC":"卡夫亨氏","GILD":"吉利德科学","AAPL":"苹果","VZ":"Verizon Comms","JNJ":"强生","TXN":"德州仪器","HD":"家得宝","KSU":"堪萨斯南方铁路","GOOG":"谷歌","NOC":"诺斯罗普格鲁曼","RTX":"雷神技术公司","TGT":"塔吉特","QCOM":"高通","EA":"艺电","REGN":"再生元制药公司","SBUX":"星巴克","NKE":"耐克","NVDA":"英伟达","EL":"雅诗兰黛","UNP":"联合太平洋","MCD":"麦当劳","MSFT":"微软","GOOGL":"谷歌A"},"source_url":"https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144745081","content_text":"Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert to inflation risks.\n\"There is probably no bigger macro issue, both tactically and strategically, than inflation and what this means for portfolios,\" said strategists led by Inigo Fraser Jenkins at Bernstein Research on Thursday.\nFraser Jenkins and his team have our call of the day: that investors should look to buy shares in companies with a long maturity of debt as an effective hedge against inflation.\nCompanies issued debt at an astounding rate through the COVID-19 pandemic. Much of it was a necessary move to meet funding needs, but for some groups it was an opportunity to take advantage of the Fed's measures supporting credit markets, which provided an ability to increase the maturity of debt, the strategists said.\nAccording to the team at Bernstein, for companies that have long maturity of debt, have issued fixed-rate debt, and are going concerns -- i.e. can continue operating while meeting financial obligations -- inflation could be a positive thing. \"Inflation would erode the real value of the debt relative to earnings (which are tied to the real economy),\" the strategists said.\n\"There is no one solution\" to finding suitable hedges for inflation, Fraser Jenkins' group said, noting that a good response may involve more equities, real assets, gold, and even crypto assets like bitcoin . But \"another possible string to the inflation-hedging bow\" is companies that emerge from the pandemic with a long maturity of debt.\n\"A basket of U.S. long debt maturity stocks has outperformed a basket of short debt maturity stocks by 7% this year and trades at more attractive valuations than their short debt maturity peers,\" Fraser Jenkins and his team added.\nCHART VIA BERNSTEIN RESEARCH.\nThere are a lot of these stocks: the strategists at Bernstein have a list of more than 80. Some of those picks include Big Tech names Apple $(AAPL)$, Alphabet $(GOOGL)$(GOOGL), Amazon $(AMZN)$, and Microsoft $(MSFT)$, as well as other technology companies like videogame developer Electronic Arts $(EA)$ and semiconductor groups Nvidia $(NVDA)$, Texas Instruments $(TXN)$, and Qualcomm $(QCOM)$.\nTelecom giants AT&T $(T)$ and Verizon $(VZ)$ are also on the list, as are retailers and consumer-products groups such as Home Depot $(HD)$, Target $(TGT)$, McDonalds $(MCD)$, Starbucks $(SBUX)$, Nike $(NKE)$, Kraft Heinz $(KHC)$, Estée Lauder $(EL)$, and Coca-Cola $(KO)$.\nHealth and biotechnology stocks like Johnson & Johnson $(JNJ)$, Pfizer $(PFE)$, Gilead Sciences $(GILD)$, Regeneron $(REGN)$, and Biogen $(BIIB)$ also make the cut, as do railroad operators Kansas City Southern $(KSU)$ and Union Pacific $(UNP)$. Defense companies Lockheed Martin $(LMT)$, Northrop Grumman $(NOC)$, and Raytheon Technologies $(RTX)$ also qualify.","news_type":1,"symbols_score_info":{"GOOGL":0.9,"VZA":0.9,"VZ":0.9,"MSFT":0.9,"QCOM":0.9,"GOOG":0.9,"PFE":0.9,"JNJ":0.9,"HD":0.9,"AAPL":0.9,"KO":0.9,"LMT":0.9,"NOC":0.9,"MCD":0.9,"NKE":0.9,"EA":0.9,"RTX":0.9,"GILD":0.9,"AMZN":0.9,"TGT":0.9,"KSU":0.9,"KHC":0.9,"NVDA":0.9,"TXN":0.9,"REGN":0.9,"UNP":0.9,"EL":0.9,"SBUX":0.9}},"isVote":1,"tweetType":1,"viewCount":1124,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3551283870649340","authorId":"3551283870649340","name":"Amy1224","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3551283870649340","idStr":"3551283870649340"},"content":"If you go up well, you can't see a decline","text":"If you go up well, you can't see a decline","html":"If you go up well, you can't see a decline"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168353403,"gmtCreate":1623953097902,"gmtModify":1703824603748,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Buy the dip!","listText":"Buy the dip!","text":"Buy the dip!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168353403","repostId":"2144405557","repostType":2,"isVote":1,"tweetType":1,"viewCount":1212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168333096,"gmtCreate":1623949477115,"gmtModify":1703824535988,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Meme stocks","listText":"Meme stocks","text":"Meme stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/168333096","repostId":"1137716821","repostType":4,"repost":{"id":"1137716821","kind":"news","pubTimestamp":1623940600,"share":"https://ttm.financial/m/news/1137716821?lang=en_US&edition=fundamental","pubTime":"2021-06-17 22:36","market":"us","language":"en","title":"With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1137716821","media":"benzinga","summary":"It seems that the market debate about whether inflation is truly temporary or could be more lingerin","content":"<div>\n<p>It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 22:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEN":"莱纳建筑公司","TSLA":"特斯拉","KR":"克罗格"},"source_url":"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137716821","content_text":"It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations for this year but still saying it thinks inflation is “transitory.” This argument may also further another tussle that’s been going on in the market—growth versus value—with growth stocks perhaps continuing to be a little worse for wear amid worries about inflation eating away at future earnings prospects.\nBut really we’re still just in the follow-up mode to the Fed’s announcement, and the selling hasn’t been that bad. There certainly hasn’t been any panic. Chair Jerome Powell did say to take the dot plot with a “big grain of salt.” Also the central bank didn’t say when it would start tapering its bond purchases, with Powell calling this month’s meeting the “talking about talking about” one.\nSo all in all, a big takeaway was that the Fed may be engaging in one of those summer traditions of easing cautiously into cold water while still trying to keep its swimsuit dry. While the market wasn’t particularly warm to what the Fed had to say, it’s not like the bottom fell out.\nIn earnings news this morning, grocery giant Kroger rung up solid earnings, raised full-year guidance, and announced a billion-dollar stock buyback … and shares were near unchanged in premarket trading. As we’ve seen in recent days, retailers can have a hard time impressing investors in the post-Covid world. Shares of homebuilder Lennar are pointing green after releasing better-than-expected earnings and offering up some positive words on the demand outlook. Remember: Homebuilders have had a tough time navigating the pandemic, with low-interest rates and high demand countered by soaring costs of labor, raw materials, and building supplies.\nAnother stock in the green—literally and figuratively—is Ford , which issued strong Q2 guidance ahead of the Deutsche Bank Auto Conference. Shares of F, which are up more than 70% this year, soared another 3% ahead of the open. F and rival U.S. automaker General MotorsGM 0.91%have grabbed the headlines in recent days amid plans to shift electric vehicle production into high gear.\nA (Somewhat) Jarring Jolt\nYesterday, stock indices quickly fell to session lows when the Fed issued projections showing much better chances of a rate hike next year. It also raised its inflation growth estimate for this year pretty sharply.\nThese moves led to thoughts among analysts that a taper of the Fed’s $120 billion a month bond-buying program might start by late this year or early next, though the Fed is sticking by it for now.\nSeven members of the Federal Open Market Committee (FOMC) now expect at least one rate hike next year, up from four who did at the Fed’s March meeting. Also, 13 FOMC members expect rates to rise in 2023, up from seven in March. The meeting basically seems to indicate we can expect a rate hike possibly by late 2023, rather than the 2024 timing projected after the March meeting.\nBut stocks did recover somewhat yesterday, and the laggard Dow Jones Industrial Average ($DJI) was able to regain the 34,000 mark when all was said and done.\nIs It Worth A Taper Tantrum?\nEven though really-cheap-money may be coming to an end sooner than some had expected, it doesn’t seem like the present situation is anything to go too crazy over. It’s unclear if the Fed will really change course until we get a handle on employment and some of the government subsidies start to dry up. Last week’s Job Openings and Labor Turnover Survey report showed a historically high level of job openings. It’s hard to imagine the Fed getting too hawkish while all those jobs are left to be filled.\nThe Fed’s actual press release didn’t change all that much from March. It did say the country is making progress on vaccinations, easing the crisis. There was no change in its asset purchase language and its aiming for inflation above 2% for some time. Even though the Fed raised its inflation projection, it continues to say inflation is “transitory.”\nFed officials continue to cite short-term supply bottlenecks caused by sharp increases in demand as the economy reopens following the pandemic. The supply shortages, they say, will fade as the year continues. Let’s hope they’re right.\nCHART OF THE DAY: IN TANDEM:The US dollar index ($DXY—purple line) and 10-Year Treasury Note Yield Index (TNX—candlestick) both popped nicely on the Fed news yesterday. It seems that the central bank may be a little more hawkish than many market participants were expecting at this juncture. Data source: Intercontinental Exchange, Cboe Global Markets. Chart source: The thinkorswim® platform. For illustrative purposes only. Past performance does not guarantee future results.\nESG Debt Accelerating:It’s not your grandfather’s market. There is still a place in many investor portfolios for companies where the bottom line is, well, the bottom line. But investing in line with environmental, social, and governance goals has taken hold in the minds of many investors. This so-called ESG investing is not only associated with stock, but also bonds. Research company BloombergNEF this month reported that money borrowed for ESG purposes has surpassed $3 trillion.\nThat sustainable debt milestone “highlights the rapid growth this once-niche corner of investing has seen lately, with the most recent trillion dollars issued in just the last eight months,” the research company said. It took almost 12 years to reach the $1 trillion mark since sustainable debt labeling began and less than two years to reach the second trillion, according to BloombergNEF.\nCharging Up:Continuing with the sustainability theme, it may seem that Tesla dominates the headlines for electric vehicles, but the company is facing increased competition from both electric vehicle upstarts like Kandi Technologies Group , Li Auto , and NIO but also from traditional automakers like General Motors and Ford . Indeed, BloombergNEF this month released its latest annual Electric Vehicle Outlook that says even with no additional policy measures global sales of zero-emission cars will rise from 4% of the market in 2020 to 70% by 2040, led by China, the United States and European economies.\nCatching The Bus:But the electric vehicle push also offers investors opportunities beyond cars. The BloombergNEF EV outlook sees global sales of zero-emission buses rising to 83%, light commercial vehicles to 60%, and medium and heavy commercial vehicles to just over 30% of their respective markets by 2040. In recent related news, a California program that provides cash vouchers to reduce the purchase price for operators of electric commercial vehicles recently said enough funding has been requested to fund more than 900 vehicles, and more funds will be available in August. One company that could benefit is Lion Electric . According to research from BMO Capital Markets, the West Coast state is the largest target market for the company’s electric school buses and trucks.\n“We understand Lion has applied for a few vouchers for customers with results to be determined within weeks,” a BMO research note said. “These could represent some orders toward what Lion needs to secure over the next 18 months to achieve our 2022 sales projection for 2,475 vehicles.” Just as with the proliferation of electric car makers, there also are a growing number of companies involved in heavier electric vehicles, including LEV, ArrivalARVL 6.42%, BYD Co. (OTCMKTS: BYDDY), Nikola Corp. . And yes, lest we forget, TSLA has been working on an electric semi-truck for years.","news_type":1,"symbols_score_info":{"KR":0.9,"TSLA":0.9,"LEN":0.9}},"isVote":1,"tweetType":1,"viewCount":696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168339605,"gmtCreate":1623949448907,"gmtModify":1703824534994,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"A lot of potential","listText":"A lot of potential","text":"A lot of potential","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168339605","repostId":"1175322624","repostType":4,"repost":{"id":"1175322624","kind":"news","pubTimestamp":1623940991,"share":"https://ttm.financial/m/news/1175322624?lang=en_US&edition=fundamental","pubTime":"2021-06-17 22:43","market":"us","language":"en","title":"Fisker Jumps on EV-Production Pact With Magna International","url":"https://stock-news.laohu8.com/highlight/detail?id=1175322624","media":".thestreet","summary":"Fisker   was higher after it said it signed an agreement under which Magna International,  the mobility technology company, would produce its electric vehicles.As part of the partnership, Fisker's all-electric Ocean SUV is expected to start production at the Aurora, Ontario, company's facility in Graz, Austria, starting Nov. 17, 2022.\"From the start of this partnership, Fisker and Magna aligned very quickly on the importance of delivering a high-quality vehicle on time,\" Chief Executive Henrik F","content":"<p>Fisker&nbsp;(<b>FSR</b>) &nbsp;was higher after it&nbsp;said&nbsp;it signed an agreement under which Magna International,&nbsp;(<b>MGA</b>)&nbsp;the mobility technology company, would produce its electric vehicles.</p>\n<p>As part of the partnership, Fisker's all-electric Ocean SUV is expected to start production at the Aurora, Ontario, company's facility in Graz, Austria, starting Nov. 17, 2022.</p>\n<p>\"From the start of this partnership, Fisker and Magna aligned very quickly on the importance of delivering a high-quality vehicle on time,\" Chief Executive Henrik Fisker said in a statement.</p>\n<p>The Graz manufacturing facility has produced more than 3.7 million vehicles for several global automakers.</p>\n<p>The agreement is \"broad-based\" covering planned volumes, manufacturing costs and quality metrics over the program's lifecycle which runs through 2029.</p>\n<p>The Ocean SUV from the Los Angeles company will use a version of a Magna-developed electric-vehicle architecture. Fisker will modify that architecture to create new intellectual property that it expects to deliver \"class-leading range\" while also lowering manufacturing costs.</p>\n<p>Fisker now expects Ocean to enter the market with a starting list price of $37,499 in the U.S., excluding electric vehicle-related subsidies, and below&nbsp;€32,000 ($38,200) in Germany (including taxes and EV-related subsidies).</p>\n<p>\"Our asset-lite model, reinforced by partners like Magna, is powering Fisker towards its planned delivery of the Ocean with features and functions exceeding our original aspirations,\" said Fisker. He added that the company is scaling rapidly.</p>\n<p>Fisker shares at last check were 3.1% higher at $18.29. Magna's shares traded on the New York Stock Exchange were off 0.5% at $92.74.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fisker Jumps on EV-Production Pact With Magna International</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFisker Jumps on EV-Production Pact With Magna International\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 22:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/fisker-higher-after-finalizing-magna-intl-production-agreement><strong>.thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Fisker (FSR)  was higher after it said it signed an agreement under which Magna International, (MGA) the mobility technology company, would produce its electric vehicles.\nAs part of the partnership, ...</p>\n\n<a href=\"https://www.thestreet.com/investing/fisker-higher-after-finalizing-magna-intl-production-agreement\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSR":"菲斯克"},"source_url":"https://www.thestreet.com/investing/fisker-higher-after-finalizing-magna-intl-production-agreement","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175322624","content_text":"Fisker (FSR)  was higher after it said it signed an agreement under which Magna International, (MGA) the mobility technology company, would produce its electric vehicles.\nAs part of the partnership, Fisker's all-electric Ocean SUV is expected to start production at the Aurora, Ontario, company's facility in Graz, Austria, starting Nov. 17, 2022.\n\"From the start of this partnership, Fisker and Magna aligned very quickly on the importance of delivering a high-quality vehicle on time,\" Chief Executive Henrik Fisker said in a statement.\nThe Graz manufacturing facility has produced more than 3.7 million vehicles for several global automakers.\nThe agreement is \"broad-based\" covering planned volumes, manufacturing costs and quality metrics over the program's lifecycle which runs through 2029.\nThe Ocean SUV from the Los Angeles company will use a version of a Magna-developed electric-vehicle architecture. Fisker will modify that architecture to create new intellectual property that it expects to deliver \"class-leading range\" while also lowering manufacturing costs.\nFisker now expects Ocean to enter the market with a starting list price of $37,499 in the U.S., excluding electric vehicle-related subsidies, and below €32,000 ($38,200) in Germany (including taxes and EV-related subsidies).\n\"Our asset-lite model, reinforced by partners like Magna, is powering Fisker towards its planned delivery of the Ocean with features and functions exceeding our original aspirations,\" said Fisker. He added that the company is scaling rapidly.\nFisker shares at last check were 3.1% higher at $18.29. Magna's shares traded on the New York Stock Exchange were off 0.5% at $92.74.","news_type":1,"symbols_score_info":{"FSR":0.9}},"isVote":1,"tweetType":1,"viewCount":1193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168330740,"gmtCreate":1623949416480,"gmtModify":1703824533510,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Great job","listText":"Great job","text":"Great job","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168330740","repostId":"2144749073","repostType":4,"isVote":1,"tweetType":1,"viewCount":1015,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168330994,"gmtCreate":1623949381818,"gmtModify":1703824532366,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Yeah right","listText":"Yeah right","text":"Yeah right","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168330994","repostId":"2144744636","repostType":4,"isVote":1,"tweetType":1,"viewCount":1073,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168397628,"gmtCreate":1623949351164,"gmtModify":1703824533842,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Test","listText":"Test","text":"Test","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168397628","repostId":"2144374429","repostType":4,"isVote":1,"tweetType":1,"viewCount":1591,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168394705,"gmtCreate":1623949324907,"gmtModify":1703824531046,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Bump bump bup","listText":"Bump bump bup","text":"Bump bump bup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168394705","isVote":1,"tweetType":1,"viewCount":1533,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168391821,"gmtCreate":1623949059663,"gmtModify":1703824522464,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Brilliant","listText":"Brilliant","text":"Brilliant","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168391821","repostId":"1108846547","repostType":4,"isVote":1,"tweetType":1,"viewCount":951,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":166641861,"gmtCreate":1624008197353,"gmtModify":1703826426041,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Ford looks good to buy&nbsp;","listText":"Ford looks good to buy&nbsp;","text":"Ford looks good to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641861","repostId":"2144172072","repostType":4,"isVote":1,"tweetType":1,"viewCount":4643,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351085,"gmtCreate":1623953132847,"gmtModify":1703824603910,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Apple will dip all the way","listText":"Apple will dip all the way","text":"Apple will dip all the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/168351085","repostId":"2144745081","repostType":2,"repost":{"id":"2144745081","kind":"highlight","pubTimestamp":1623999815,"share":"https://ttm.financial/m/news/2144745081?lang=en_US&edition=fundamental","pubTime":"2021-06-18 15:03","market":"us","language":"en","title":"Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say","url":"https://stock-news.laohu8.com/highlight/detail?id=2144745081","media":"MarketWatch","summary":"Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indicatio","content":"<p>Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert to inflation risks.</p>\n<p>\"There is probably no bigger macro issue, both tactically and strategically, than inflation and what this means for portfolios,\" said strategists led by Inigo Fraser Jenkins at Bernstein Research on Thursday.</p>\n<p>Fraser Jenkins and his team have our call of the day: that investors should look to buy shares in companies with a long maturity of debt as an effective hedge against inflation.</p>\n<p>Companies issued debt at an astounding rate through the COVID-19 pandemic. Much of it was a necessary move to meet funding needs, but for some groups it was an opportunity to take advantage of the Fed's measures supporting credit markets, which provided an ability to increase the maturity of debt, the strategists said.</p>\n<p>According to the team at Bernstein, for companies that have long maturity of debt, have issued fixed-rate debt, and are going concerns -- i.e. can continue operating while meeting financial obligations -- inflation could be a positive thing. \"Inflation would erode the real value of the debt relative to earnings (which are tied to the real economy),\" the strategists said.</p>\n<p>\"There is no one solution\" to finding suitable hedges for inflation, Fraser Jenkins' group said, noting that a good response may involve more equities, real assets, gold, and even crypto assets like bitcoin . But \"another possible string to the inflation-hedging bow\" is companies that emerge from the pandemic with a long maturity of debt.</p>\n<p>\"A basket of U.S. long debt maturity stocks has outperformed a basket of short debt maturity stocks by 7% this year and trades at more attractive valuations than their short debt maturity peers,\" Fraser Jenkins and his team added.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1aca07448aa8168cf9edc9e49d933435\" tg-width=\"1260\" tg-height=\"672\" referrerpolicy=\"no-referrer\"><span>CHART VIA BERNSTEIN RESEARCH.</span></p>\n<p>There are a lot of these stocks: the strategists at Bernstein have a list of more than 80. Some of those picks include Big Tech names Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>(GOOGL), Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, and Microsoft <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, as well as other technology companies like videogame developer Electronic Arts <a href=\"https://laohu8.com/S/EA\">$(EA)$</a> and semiconductor groups Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, Texas Instruments <a href=\"https://laohu8.com/S/TXN\">$(TXN)$</a>, and Qualcomm <a href=\"https://laohu8.com/S/QCOM\">$(QCOM)$</a>.</p>\n<p>Telecom giants AT&amp;T <a href=\"https://laohu8.com/S/T\">$(T)$</a> and Verizon <a href=\"https://laohu8.com/S/VZ\">$(VZ)$</a> are also on the list, as are retailers and consumer-products groups such as Home Depot <a href=\"https://laohu8.com/S/HD\">$(HD)$</a>, Target <a href=\"https://laohu8.com/S/TGT\">$(TGT)$</a>, McDonalds <a href=\"https://laohu8.com/S/MCD\">$(MCD)$</a>, Starbucks <a href=\"https://laohu8.com/S/SBUX\">$(SBUX)$</a>, Nike <a href=\"https://laohu8.com/S/NKE\">$(NKE)$</a>, Kraft Heinz <a href=\"https://laohu8.com/S/KHC\">$(KHC)$</a>, Estée Lauder <a href=\"https://laohu8.com/S/EL\">$(EL)$</a>, and Coca-Cola <a href=\"https://laohu8.com/S/KO\">$(KO)$</a>.</p>\n<p>Health and biotechnology stocks like Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>, Gilead Sciences <a href=\"https://laohu8.com/S/GILD\">$(GILD)$</a>, Regeneron <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a>, and Biogen <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> also make the cut, as do railroad operators Kansas City Southern <a href=\"https://laohu8.com/S/KSU\">$(KSU)$</a> and Union Pacific <a href=\"https://laohu8.com/S/UNP\">$(UNP)$</a>. Defense companies Lockheed Martin <a href=\"https://laohu8.com/S/LMT\">$(LMT)$</a>, Northrop Grumman <a href=\"https://laohu8.com/S/NOC\">$(NOC)$</a>, and Raytheon Technologies <a href=\"https://laohu8.com/S/RTX\">$(RTX)$</a> also qualify.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Looking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLooking for hedges against inflation? Try Apple, Nike, Verizon and stocks with this in common, strategists say\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 15:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert...</p>\n\n<a href=\"https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMT":"洛克希德马丁","KO":"可口可乐","PFE":"辉瑞","AMZN":"亚马逊","KHC":"卡夫亨氏","GILD":"吉利德科学","AAPL":"苹果","VZ":"Verizon Comms","JNJ":"强生","TXN":"德州仪器","HD":"家得宝","KSU":"堪萨斯南方铁路","GOOG":"谷歌","NOC":"诺斯罗普格鲁曼","RTX":"雷神技术公司","TGT":"塔吉特","QCOM":"高通","EA":"艺电","REGN":"再生元制药公司","SBUX":"星巴克","NKE":"耐克","NVDA":"英伟达","EL":"雅诗兰黛","UNP":"联合太平洋","MCD":"麦当劳","MSFT":"微软","GOOGL":"谷歌A"},"source_url":"https://www.marketwatch.com/story/looking-for-hedges-against-inflation-try-apple-nike-verizon-and-stocks-with-this-in-common-strategists-say-11623928849?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144745081","content_text":"Stocks are set for a poor performance on Thursday, as markets absorb the Federal Reserve's indication that interest rate increases are coming sooner than expected, while the central bank remains alert to inflation risks.\n\"There is probably no bigger macro issue, both tactically and strategically, than inflation and what this means for portfolios,\" said strategists led by Inigo Fraser Jenkins at Bernstein Research on Thursday.\nFraser Jenkins and his team have our call of the day: that investors should look to buy shares in companies with a long maturity of debt as an effective hedge against inflation.\nCompanies issued debt at an astounding rate through the COVID-19 pandemic. Much of it was a necessary move to meet funding needs, but for some groups it was an opportunity to take advantage of the Fed's measures supporting credit markets, which provided an ability to increase the maturity of debt, the strategists said.\nAccording to the team at Bernstein, for companies that have long maturity of debt, have issued fixed-rate debt, and are going concerns -- i.e. can continue operating while meeting financial obligations -- inflation could be a positive thing. \"Inflation would erode the real value of the debt relative to earnings (which are tied to the real economy),\" the strategists said.\n\"There is no one solution\" to finding suitable hedges for inflation, Fraser Jenkins' group said, noting that a good response may involve more equities, real assets, gold, and even crypto assets like bitcoin . But \"another possible string to the inflation-hedging bow\" is companies that emerge from the pandemic with a long maturity of debt.\n\"A basket of U.S. long debt maturity stocks has outperformed a basket of short debt maturity stocks by 7% this year and trades at more attractive valuations than their short debt maturity peers,\" Fraser Jenkins and his team added.\nCHART VIA BERNSTEIN RESEARCH.\nThere are a lot of these stocks: the strategists at Bernstein have a list of more than 80. Some of those picks include Big Tech names Apple $(AAPL)$, Alphabet $(GOOGL)$(GOOGL), Amazon $(AMZN)$, and Microsoft $(MSFT)$, as well as other technology companies like videogame developer Electronic Arts $(EA)$ and semiconductor groups Nvidia $(NVDA)$, Texas Instruments $(TXN)$, and Qualcomm $(QCOM)$.\nTelecom giants AT&T $(T)$ and Verizon $(VZ)$ are also on the list, as are retailers and consumer-products groups such as Home Depot $(HD)$, Target $(TGT)$, McDonalds $(MCD)$, Starbucks $(SBUX)$, Nike $(NKE)$, Kraft Heinz $(KHC)$, Estée Lauder $(EL)$, and Coca-Cola $(KO)$.\nHealth and biotechnology stocks like Johnson & Johnson $(JNJ)$, Pfizer $(PFE)$, Gilead Sciences $(GILD)$, Regeneron $(REGN)$, and Biogen $(BIIB)$ also make the cut, as do railroad operators Kansas City Southern $(KSU)$ and Union Pacific $(UNP)$. Defense companies Lockheed Martin $(LMT)$, Northrop Grumman $(NOC)$, and Raytheon Technologies $(RTX)$ also qualify.","news_type":1,"symbols_score_info":{"GOOGL":0.9,"VZA":0.9,"VZ":0.9,"MSFT":0.9,"QCOM":0.9,"GOOG":0.9,"PFE":0.9,"JNJ":0.9,"HD":0.9,"AAPL":0.9,"KO":0.9,"LMT":0.9,"NOC":0.9,"MCD":0.9,"NKE":0.9,"EA":0.9,"RTX":0.9,"GILD":0.9,"AMZN":0.9,"TGT":0.9,"KSU":0.9,"KHC":0.9,"NVDA":0.9,"TXN":0.9,"REGN":0.9,"UNP":0.9,"EL":0.9,"SBUX":0.9}},"isVote":1,"tweetType":1,"viewCount":1124,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3551283870649340","authorId":"3551283870649340","name":"Amy1224","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3551283870649340","idStr":"3551283870649340"},"content":"If you go up well, you can't see a decline","text":"If you go up well, you can't see a decline","html":"If you go up well, you can't see a decline"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168333096,"gmtCreate":1623949477115,"gmtModify":1703824535988,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Meme stocks","listText":"Meme stocks","text":"Meme stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/168333096","repostId":"1137716821","repostType":4,"repost":{"id":"1137716821","kind":"news","pubTimestamp":1623940600,"share":"https://ttm.financial/m/news/1137716821?lang=en_US&edition=fundamental","pubTime":"2021-06-17 22:36","market":"us","language":"en","title":"With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1137716821","media":"benzinga","summary":"It seems that the market debate about whether inflation is truly temporary or could be more lingerin","content":"<div>\n<p>It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Fed Seeing Higher Inflation, Growth Stocks Could be In The Spotlight Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 22:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations ...</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEN":"莱纳建筑公司","TSLA":"特斯拉","KR":"克罗格"},"source_url":"https://www.benzinga.com/news/earnings/21/06/21608060/with-fed-seeing-higher-inflation-growth-stocks-could-be-in-the-spotlight-today","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137716821","content_text":"It seems that the market debate about whether inflation is truly temporary or could be more lingering has heated up a bit.\nThe Fed added more fuel to that fire by raising its inflation expectations for this year but still saying it thinks inflation is “transitory.” This argument may also further another tussle that’s been going on in the market—growth versus value—with growth stocks perhaps continuing to be a little worse for wear amid worries about inflation eating away at future earnings prospects.\nBut really we’re still just in the follow-up mode to the Fed’s announcement, and the selling hasn’t been that bad. There certainly hasn’t been any panic. Chair Jerome Powell did say to take the dot plot with a “big grain of salt.” Also the central bank didn’t say when it would start tapering its bond purchases, with Powell calling this month’s meeting the “talking about talking about” one.\nSo all in all, a big takeaway was that the Fed may be engaging in one of those summer traditions of easing cautiously into cold water while still trying to keep its swimsuit dry. While the market wasn’t particularly warm to what the Fed had to say, it’s not like the bottom fell out.\nIn earnings news this morning, grocery giant Kroger rung up solid earnings, raised full-year guidance, and announced a billion-dollar stock buyback … and shares were near unchanged in premarket trading. As we’ve seen in recent days, retailers can have a hard time impressing investors in the post-Covid world. Shares of homebuilder Lennar are pointing green after releasing better-than-expected earnings and offering up some positive words on the demand outlook. Remember: Homebuilders have had a tough time navigating the pandemic, with low-interest rates and high demand countered by soaring costs of labor, raw materials, and building supplies.\nAnother stock in the green—literally and figuratively—is Ford , which issued strong Q2 guidance ahead of the Deutsche Bank Auto Conference. Shares of F, which are up more than 70% this year, soared another 3% ahead of the open. F and rival U.S. automaker General MotorsGM 0.91%have grabbed the headlines in recent days amid plans to shift electric vehicle production into high gear.\nA (Somewhat) Jarring Jolt\nYesterday, stock indices quickly fell to session lows when the Fed issued projections showing much better chances of a rate hike next year. It also raised its inflation growth estimate for this year pretty sharply.\nThese moves led to thoughts among analysts that a taper of the Fed’s $120 billion a month bond-buying program might start by late this year or early next, though the Fed is sticking by it for now.\nSeven members of the Federal Open Market Committee (FOMC) now expect at least one rate hike next year, up from four who did at the Fed’s March meeting. Also, 13 FOMC members expect rates to rise in 2023, up from seven in March. The meeting basically seems to indicate we can expect a rate hike possibly by late 2023, rather than the 2024 timing projected after the March meeting.\nBut stocks did recover somewhat yesterday, and the laggard Dow Jones Industrial Average ($DJI) was able to regain the 34,000 mark when all was said and done.\nIs It Worth A Taper Tantrum?\nEven though really-cheap-money may be coming to an end sooner than some had expected, it doesn’t seem like the present situation is anything to go too crazy over. It’s unclear if the Fed will really change course until we get a handle on employment and some of the government subsidies start to dry up. Last week’s Job Openings and Labor Turnover Survey report showed a historically high level of job openings. It’s hard to imagine the Fed getting too hawkish while all those jobs are left to be filled.\nThe Fed’s actual press release didn’t change all that much from March. It did say the country is making progress on vaccinations, easing the crisis. There was no change in its asset purchase language and its aiming for inflation above 2% for some time. Even though the Fed raised its inflation projection, it continues to say inflation is “transitory.”\nFed officials continue to cite short-term supply bottlenecks caused by sharp increases in demand as the economy reopens following the pandemic. The supply shortages, they say, will fade as the year continues. Let’s hope they’re right.\nCHART OF THE DAY: IN TANDEM:The US dollar index ($DXY—purple line) and 10-Year Treasury Note Yield Index (TNX—candlestick) both popped nicely on the Fed news yesterday. It seems that the central bank may be a little more hawkish than many market participants were expecting at this juncture. Data source: Intercontinental Exchange, Cboe Global Markets. Chart source: The thinkorswim® platform. For illustrative purposes only. Past performance does not guarantee future results.\nESG Debt Accelerating:It’s not your grandfather’s market. There is still a place in many investor portfolios for companies where the bottom line is, well, the bottom line. But investing in line with environmental, social, and governance goals has taken hold in the minds of many investors. This so-called ESG investing is not only associated with stock, but also bonds. Research company BloombergNEF this month reported that money borrowed for ESG purposes has surpassed $3 trillion.\nThat sustainable debt milestone “highlights the rapid growth this once-niche corner of investing has seen lately, with the most recent trillion dollars issued in just the last eight months,” the research company said. It took almost 12 years to reach the $1 trillion mark since sustainable debt labeling began and less than two years to reach the second trillion, according to BloombergNEF.\nCharging Up:Continuing with the sustainability theme, it may seem that Tesla dominates the headlines for electric vehicles, but the company is facing increased competition from both electric vehicle upstarts like Kandi Technologies Group , Li Auto , and NIO but also from traditional automakers like General Motors and Ford . Indeed, BloombergNEF this month released its latest annual Electric Vehicle Outlook that says even with no additional policy measures global sales of zero-emission cars will rise from 4% of the market in 2020 to 70% by 2040, led by China, the United States and European economies.\nCatching The Bus:But the electric vehicle push also offers investors opportunities beyond cars. The BloombergNEF EV outlook sees global sales of zero-emission buses rising to 83%, light commercial vehicles to 60%, and medium and heavy commercial vehicles to just over 30% of their respective markets by 2040. In recent related news, a California program that provides cash vouchers to reduce the purchase price for operators of electric commercial vehicles recently said enough funding has been requested to fund more than 900 vehicles, and more funds will be available in August. One company that could benefit is Lion Electric . According to research from BMO Capital Markets, the West Coast state is the largest target market for the company’s electric school buses and trucks.\n“We understand Lion has applied for a few vouchers for customers with results to be determined within weeks,” a BMO research note said. “These could represent some orders toward what Lion needs to secure over the next 18 months to achieve our 2022 sales projection for 2,475 vehicles.” Just as with the proliferation of electric car makers, there also are a growing number of companies involved in heavier electric vehicles, including LEV, ArrivalARVL 6.42%, BYD Co. (OTCMKTS: BYDDY), Nikola Corp. . And yes, lest we forget, TSLA has been working on an electric semi-truck for years.","news_type":1,"symbols_score_info":{"KR":0.9,"TSLA":0.9,"LEN":0.9}},"isVote":1,"tweetType":1,"viewCount":696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641587,"gmtCreate":1624008226649,"gmtModify":1703826426373,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"This is so sad","listText":"This is so sad","text":"This is so sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641587","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=en_US&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1,"symbols_score_info":{"ORPH":0.9}},"isVote":1,"tweetType":1,"viewCount":3548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166644647,"gmtCreate":1624008474089,"gmtModify":1703826433205,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Shell out more money","listText":"Shell out more money","text":"Shell out more money","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166644647","repostId":"1181667218","repostType":4,"isVote":1,"tweetType":1,"viewCount":2507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163365217,"gmtCreate":1623860001839,"gmtModify":1703821809851,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"How do we ultimately say who \"deserves\" it.","listText":"How do we ultimately say who \"deserves\" it.","text":"How do we ultimately say who \"deserves\" it.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/163365217","repostId":"2143797877","repostType":4,"isVote":1,"tweetType":1,"viewCount":513,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168393463,"gmtCreate":1623949017552,"gmtModify":1703824521485,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Wow so many comments here","listText":"Wow so many comments here","text":"Wow so many comments here","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/168393463","repostId":"2144742672","repostType":4,"isVote":1,"tweetType":1,"viewCount":460,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166642240,"gmtCreate":1624008407380,"gmtModify":1703826430938,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Uh oh, maybe business will fold soon","listText":"Uh oh, maybe business will fold soon","text":"Uh oh, maybe business will fold soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166642240","repostId":"1176081814","repostType":4,"isVote":1,"tweetType":1,"viewCount":3006,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166648341,"gmtCreate":1624008259483,"gmtModify":1703826427179,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Wow who would've guessed","listText":"Wow who would've guessed","text":"Wow who would've guessed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166648341","repostId":"1113093847","repostType":4,"isVote":1,"tweetType":1,"viewCount":2686,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168330740,"gmtCreate":1623949416480,"gmtModify":1703824533510,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"htmlText":"Great job","listText":"Great job","text":"Great job","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168330740","repostId":"2144749073","repostType":4,"isVote":1,"tweetType":1,"viewCount":1015,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}